vutrisiran 25 MG in 0.5 ML Prefilled Syringe
- RxCUI
- 2604788
- RxNorm name
- vutrisiran 25 MG in 0.5 ML Prefilled Syringe
- Display name
- vutrisiran 25 MG in 0.5 ML Prefilled Syringe
- Full name
- vutrisiran 25 MG in 0.5 ML Prefilled Syringe
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:08
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AMVUTTRA | VUTRISIRAN | Alnylam Pharmaceuticals, Inc. | 8db0facb-81b6-4006-9239-27dc6409c5d3 | 2025-11-06 | Warnings, Adverse reactions | 2604788 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 8db0facb-81b6-4006-9239-27dc6409c5d3 | vutrisiran 25 MG in 0.5 ML Prefilled Syringe | PSN | 8 | These highlights do not include all the information needed to use AMVUTTRA ® safely and effectively. See full prescribing information for AMVUTTRA. AMVUTTRA (vutrisiran) injection, for subcutaneous use Initial U.S. Approval: 2022 | 20251106 |
| 8db0facb-81b6-4006-9239-27dc6409c5d3 | vutrisiran 25 MG (as vutrisiran sodium 26.5 MG) per 0.5 ML Prefilled Syringe | SY | 8 | These highlights do not include all the information needed to use AMVUTTRA ® safely and effectively. See full prescribing information for AMVUTTRA. AMVUTTRA (vutrisiran) injection, for subcutaneous use Initial U.S. Approval: 2022 | 20251106 |
| 8db0facb-81b6-4006-9239-27dc6409c5d3 | 0.5 ML vutrisiran 50 MG/ML Prefilled Syringe | SCD | 8 | These highlights do not include all the information needed to use AMVUTTRA ® safely and effectively. See full prescribing information for AMVUTTRA. AMVUTTRA (vutrisiran) injection, for subcutaneous use Initial U.S. Approval: 2022 | 20251106 |